Table 1.
Results from cytokine panels obtained clinically to guide immunomodulatory therapies.
| Cytokine (pg/mL) |
Case 1:
day +54 |
Case 2:
day +64 |
Case 2:
day +92 |
|---|---|---|---|
| IL-1β | <5 | <5 | <5 |
| IL-2 | <5 | <5 | <5 |
| IL-4 | 75 | <5 | <5 |
| IL-5 | 5 | 21 | 21 |
| IL-6 | 4,353 | 45 | 170 |
| IL-8 | 154 | 86 | <5 |
| IL-10 | 60 | 184 | 26 |
| IL-12 | – | <5 | <5 |
| IL-13 | – | <5 | <5 |
| IL-18 | 8,111 | – | – |
| IFN-γ | 15 | <5 | 13 |
| TNF-α | 2 | – | – |
| GMCSF | 2 | – | – |
| CXCL9 | 1,681 | – | – |
| sCD163 | 5,575 | – | – |
| sIL-2R | 5,835 | 9,330 | 2,739 |
IL, interleukin; IFN, interferon; TNF, tumor necrosis factor; GMCSF, granulocyte–macrophage colony-stimulating factor; CXCL, C–X–C motif chemokine ligand; CD, cluster of differentiation.